Refractory alloys like Niobium C103 are increasingly being used in conjunction with 3D printing for hypersonic applications.

Three different doses of Niktimvo all had high rates of response among patients with recurrent or refractory ...

From solutions for the regenerator and the melting end to the new, advanced FouRrath4 feeder expendables series, newly developed channel blocks and innovative ceramic hot gas filter elements, Rath ...

BYON-4413 is under clinical development by Byondis and currently in Phase I for Refractory Acute Myeloid Leukemia.

A new study demonstrates that the combination of lenalidomide (Revlimid) and obinutuzumab (Gazyva) is effective and ...

Drug maker GSK plc (GSK, GSK.L) announced Tuesday that Blenrep (belantamab mafodotin) combinations in relapsed/refractory multiple ...

The refractory cement market is essential for industries requiring materials that can withstand high temperatures, such as steel production, cement manufacturing, and petrochemicals. Driven by the ...

During a Case-Based Roundtable® event, Samer A. Al'Hadidi, MD, MS, discussed the CARTITUDE-4 trial of cilta-cel in patients ...

During a Case-Based Roundtable® event, Ajay Nooka, MD, MPH, discussed adverse events related to talquetamab for multiple ...

Physicians in the US, Germany, and France show gaps in their knowledge of the treatment of of refractory/relapsed chronic ...

Incyte (INCY) and Syndax Pharmaceuticals (SNDX) announced that results from the pivotal Phase 2 AGAVE-201 trial of ...

Poseida Therapeutics’ P-BCMA-ALLO1 receives US FDA RMAT designation to treat relapsed/refractory multiple myeloma: San Diego Tuesday, September 17, 2024, 17:00 Hrs [IST] Poseida ...